ClearPoint Neuro, Inc.

ClearPoint Neuro is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. We uniquely provide both established clinical products as well as pre-clinical development services for controlled drug and device delivery. ClearPoint Neuro is engaged with healthcare and research centers in North America, Europe, Asia, and South America.

Our mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy.

ClearPoint Neuro’s comprehensive approach combines real-time direct imaging with hardware and software, allowing neurosurgeons to make intraprocedural adjustments with unparalleled precision. We offer a range of innovative solutions, including the ClearPoint Prism Neuro Laser System, IRRAflow System, and ClearPoint Array Platform, supporting both research and clinical applications.

Founded in 1998 and headquartered in Solana Beach, California, ClearPoint Neuro has grown to a team of 150 employees and boasts over 90 global neurosurgery centers utilizing our technology. We are committed to continuous innovation and collaboration within the CNS drug delivery landscape.